Deutsch English Français

Contact

EP2295413

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP2295413

EP2295413 - Indazole compounds useful as protein kinase inhibitors [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 20.12.2013 Database last updated on 24.04.2024
Most recent event Tooltip	20.12.2013	Application deemed to be withdrawn	published on 22.01.2014 [2014/04]
Applicant(s)	For all designated states Vertex Pharmaceuticals Incorporated 130 Waverly Street Cambridge, MA 02139 / US
	[2011/11]
Inventor(s)	01 / Binch, Hayley 2 Orchard Way, Harwell Oxon, OX11 0L Q / GB
	02 / Brenchley, Guy 12 Boucher Close, Grove Wantage Oxon, OX12 0NE / GB
	03 / Golec, Julian, M., C. Garden House Woolstone Faringdon, OX SN7 7QL / GB
	04 / Knegtel, Ronald 92 Andersey Way, Abingdon Oxon Northwest, OX145 / GB
	05 / Mortimore, Michael Walrus House, 156 The Hill Burford, Oxfordshire OX18 4QY / GB
	06 / Patel, Sanjay 2 Alder Close, Abingdon Oxon, OX14 1YG / GB
	07 / Rutherford, Alistair 11 Reade Avenue Abingdon, Oxfordshire OX14 34E / GB
	[2011/19]
Former [2011/11]	01 / Binch, Hayley 2 Orchard Way, Harwell Oxon, OX11 0L Q / GB
	02 / Brenchley, Guy 12 Boucher Close, Grove Wantage Oxon, OX12 0NE / GB
	03 / Golec, Julian, M., C. 8 Manor Farm, Chapel Road, Ashbury Swindon, Wiltshire SN6 8LS / GB
	04 / Knegtel, Ronald 92 Andersey Way, Abingdon Oxon Northwest, OX145 / GB
	05 / Mortimore, Michael Walrus House, 156 The Hill Burford, Oxfordshire OX18 4QY / GB
	06 / Patel, Sanjay 2 Alder Close, Abingdon Oxon, OX14 1YG / GB
	07 / Rutherford, Alistair 11 Reade Avenue Abingdon, Oxfordshire OX14 34E / GB
Representative(s)	Cohausz & Florack Patent- & Rechtsanwälte Partnerschaftsgesellschaft mbB Bleichstraße 14 40211 Düsseldorf / DE
	[N/P]
Former [2011/11]	Cohausz & Florack Patent- und Rechtsanwälte Partnerschaftsgesellschaft Bleichstraße 14 40211 Düsseldorf / DE
Application number, filing date	10181668.4	23.01.2003
	[2011/11]
Priority number, date	US20020351597P	25.01.2002 Original published format: US 351597 P
	[2011/11]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	EP2295413
	Date:	16.03.2011
	Language:	EN
	[2011/11]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	15.02.2011
Classification	IPC:	C07D231/56, C07D401/12, A61K31/416, C07D403/12, C07D405/12, C07D413/12, C07D409/12, C07D417/12, A61P35/00	[2011/11]
	CPC:	C07D417/12 (EP,US); A61K31/416 (KR); A61K31/4162 (KR); A61K31/53 (KR); A61P1/16 (EP); A61P11/06 (EP); (+) A61P19/00 (EP); A61P19/02 (EP); A61P19/10 (EP); A61P25/28 (EP); A61P29/00 (EP); A61P3/10 (EP); A61P31/12 (EP); A61P31/18 (EP); A61P35/00 (EP); A61P37/02 (EP); A61P37/08 (EP); A61P43/00 (EP); A61P5/00 (EP); A61P7/00 (EP); A61P9/00 (EP); A61P9/04 (EP); A61P9/08 (EP); A61P9/10 (EP); A61P9/12 (EP); C07D231/56 (EP,US); C07D401/12 (EP,US); C07D403/12 (EP,US); C07D405/12 (EP,US); C07D409/12 (EP,US); C07D413/12 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, SE, SI, SK, TR [2011/11]
Title	German:	Indazolverbindungen als Proteinkinasehemmer	[2011/11]
	English:	Indazole compounds useful as protein kinase inhibitors	[2011/11]
	French:	Composés d'indazole utiles en tant qu'inhibiteurs de protéines kinases	[2011/11]
Examination procedure	15.09.2011	Examination requested [2011/43]
	23.12.2011	Amendment by applicant (claims and/or description)
	29.04.2013	Despatch of a communication from the examining division (Time limit: M04)
	01.08.2013	Application deemed to be withdrawn, date of legal effect [2014/04]
	18.09.2013	Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2014/04]
Parent application(s) Tooltip	EP03708869.7 / EP1467972
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030708869) is 11.09.2008
Request for further processing for:	The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
	23.12.2011	Request for further processing filed
	23.12.2011	Full payment received (date of receipt of payment) Request granted
	08.02.2012	Decision despatched
Fees paid	Renewal fee
	25.03.2011	Renewal fee patent year 03
	25.03.2011	Renewal fee patent year 04
	25.03.2011	Renewal fee patent year 05
	25.03.2011	Renewal fee patent year 06
	25.03.2011	Renewal fee patent year 07
	25.03.2011	Renewal fee patent year 08
	25.01.2011	Renewal fee patent year 09
	25.01.2012	Renewal fee patent year 10
	Penalty fee
	Additional fee for renewal fee
	29.09.2010	03 M06 Fee paid on 25.03.2011
	29.09.2010	04 M06 Fee paid on 25.03.2011
	29.09.2010	05 M06 Fee paid on 25.03.2011
	29.09.2010	06 M06 Fee paid on 25.03.2011
	29.09.2010	07 M06 Fee paid on 25.03.2011
	29.09.2010	08 M06 Fee paid on 25.03.2011
	31.01.2013	11 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO0156988 (KIRIN BREWERY [JP], et al) [X] 1-12,14-18 * example -; claims 1,4,5 *;
		[XP]EP1256574 (KIRIN BREWERY [JP]);
		[X]WO0185719 (SCHERING AG [DE], et al) [X] 1,2,14-17 * example 11; claim - *;
		[XP]WO02083648 (EISAI CO LTD [JP], et al) [XP] 1-12,14-18 * example -; claim 1 *
	by applicant	WO0210137
		JPS50130759B
		US6099562
		US5886026
		US5304121
		- KHWAJA, A., NATURE, (1999), vol. 401, pages 33 - 34
		- YUAN, Z.Q. ET AL., ONCOGENE, (2000), vol. 19, pages 2324 - 2330
		- NAMIKAWA, K. ET AL., J NEUROSCI., (2000), vol. 20, pages 2875 - 2886
		- CHENG, J.Q., PROC. NATL. ACAD. SCI. USA, (1992), vol. 89, pages 9267 - 9271
		- BRODBECK, D. ET AL., J. BIOL. CHEM, (1999), vol. 274, pages 9133 - 9136
		- KULIK ET AL., MOL. CELL. BIOL., (1997), vol. 17, pages 1595 - 1606
		- HEMMINGS, B.A., SCIENCE, (1997), vol. 275, pages 628 - 630
		- CALERA, M.R. ET AL., BIOL. CHEM., (1998), vol. 273, pages 7201 - 7204
		- ALESSI, D.R. ET AL., CURR. OPIN. GENET. DEV., (1998), vol. 8, pages 55 - 62
		- CHENG, J.Q. ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1992), vol. 89, pages 9267 - 9271
		- CHENG, J. Q. ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1996), vol. 93, pages 3636 - 3641
		- BELLACOSA ET AL., INT. J. CANCER, (1995), vol. 64, pages 280 - 285
		- BEEBE, S.J., SEMIN. CANCER BIOL., (1994), vol. 5, pages 285 - 294
		- MCKNIGHT, G.S. ET AL., RECENT PROG. HORM. RES., (1988), vol. 44, page 307
		- BEEBE, S.J. ET AL., J. BIOI. CHEM., (1992), vol. 267, pages 25505 - 25512
		- BECKER, D. ET AL., ONCOGENE, (1990), vol. 5, page 1133
		- ISHIZAKI, T. ET AL., EMBO J, (1996), vol. 15, pages 1885 - 1893
		- CHITALEY ET AL., CURR. HYPERTENS. REP., (200104), vol. 3, no. 2, pages 139 - 144
		- UEHATA, M. ET AL., NATURE, (1997), vol. 389, pages 990 - 994
		- CHITALEY, K. ET AL., NATURE MEDICINE, (2001), vol. 7, pages 119 - 122
		- UCHIDA, S. ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (2000), vol. 269, no. 2, pages 633 - 40
		- BITO, H. ET AL., NEURON, (2000), vol. 26, pages 431 - 441
		- TAKAMURA, M. ET AL., HEPATOLOGY, (2001), vol. 33, pages 577 - 581
		- GENDA, T. ET AL., HEPATOLOGY, (1999), vol. 30, pages 1027 - 1036
		- RAO ET AL., INVEST. OPHTHALMOL. VIS. SCI., (2001), vol. 42, pages 1029 - 37
		- ISHIZUKA, T. ET AL., J. IMMUNOL., (2001), vol. 167, pages 2298 - 2304
		- SMIMOKAWA ET AL., ARTERIOSCLER. THROMB. VASC. BIOL., (2000), vol. 11, pages 2351 - 2358
		- LOU, Z. ET AL., J. IMMUNOL., (2001), vol. 167, pages 5749 - 5757
		- SEAHOLTZ ET AL., CIRC. RES., (1999), vol. 84, pages 1186 - 1193
		- YOSHII ET AL., AM. J. RESPIR. CELL MOL. BIOL., (1999), vol. 20, pages 1190 - 1200
		- KUWAHARA, K. ET AL., FEBS LETT., (1999), vol. 452, pages 314 - 318
		- VOLAREVIC, S. ET AL., PROG. NUCLEIC ACID RES. MOL. BIOL., (2001), vol. 65, pages 101 - 186
		- COFFER, P.J. ET AL., BIOEHEM. BIOPHYS. RES. COMMUN, (1994), vol. 198, no. 7, pages 780 - 786
		- KUO, C.J. ET AL., NATURE, (1992), vol. 358, pages 70 - 73
		- ALESSI, D.R., CURR. BIOL., (1998), vol. 8, pages 69 - 81
		- ALESSI, D. ET AL., BIOCHEM SOC. TRANS, (2001), vol. 29, page 1
		- AVRUCH, J. ET AL., PROG. MOL SUBCELL. BIOL., (2001), vol. 26, page 115
		- FRöDIN, M. ET AL., EMBO J., (2000), vol. 19, pages 2924 - 2934
		- LAWLOR, M.A. ET AL., J. CELL SCI., (2001), vol. 114, pages 2903 - 2910
		- LAWLOR, M.A. ET AL., EMBO J., (2002), vol. 21, pages 3728 - 3738
		- BELHAM, C. ET AL., CURR. BIOL., (1999), vol. 9, pages R93 - R96
		- GRAFF, J.R., EXPERT OPIN, THER. TARGETS, (2002), vol. 6, pages 103 - 113
		- BROGNARD, J. ET AL., CANCER RES., (2001), vol. 61, pages 3986 - 3997
		- FLYNN, P. ET AL., CURR. BIOL., (2000), vol. 10, pages 1439 - 1442
		- HANAHAN, D. ET AL., CELL, (2000), vol. 100, pages 57 - 70
		- TENG, D.H. ET AL., CANCER RES., (1997), vol. 57, pages 5221 - 5225
		- CHENG, J.Q. ET AL., PROC. NATL ACAD. SCI., (1996), vol. 93, pages 3636 - 3641
		- INT. J. CANCER, (1995), vol. 64, page 280
		- GRAFF, J.R., EXPERT OPIN. THER. TARGETS, (2002), vol. 6, pages 103 - 113
		- AM. J. PATHOL., (2001), vol. 159, page 431
		- CHENG, J.Q. ET AL., PROC. NATL. ACAD SCI., (1996), vol. 93, pages 3636 - 3641
		- NEOPLASIA, (2001), vol. 3, page 278
		- HAYAKAWA, J. ET AL., CANCER RES., (2000), vol. 60, pages 5988 - 5994
		- MOL. CANCER THER., (2002), vol. 1, page 707
		- ARICO, S. ET AL., J. BIOL CHEM., (2002), vol. 277, pages 27613 - 27621
		- ENDOCRINOLOGY, (2001), vol. 142, page 4795
		- THAKKAR, H. ET AL., J. BIOL. CHEM., (2001), vol. 276, pages 38361 - 38369
		- CHEN, X. ET AL., ONCOGENE, (2001), vol. 20, pages 6073 - 6083
		- HENKE ET AL., J. MED CHEM., (1997), vol. 40, page 2706
	- BELLAMY ET AL., TETRAHEDRON LETT., (1984), vol. 25, page 839
	- BOYER ET AL., J CHEM. RES. MINIPRINT, (1990), vol. 11, page 2601
	- PAMELL ET AL., J. CHEM. SOC., (1959), page 2363
	- HERNANDEZ ET AL., J. ORG. CHEM., (1995), vol. 60, page 2683
	- DAVIES ET AL., J. ORG. CHEM., (1988), vol. 53, page 2087
	- BENCHIDIMI ET AL., J HET. CHEM., (1979), vol. 16, page 1599
	- PRAGER ET AL., AUST. J. CHEM., (1997), vol. 50, page 813
	- PFANNSTIEL, K., BER1942, vol. 75B, page 1096
	- VICENTE, J ET AL., HETEROCYCLES, (1997), vol. 45, no. 1, page 129
	- FOX ET AL., PROTEIN SCI., (1998), vol. 7, page 2249
	- PITT; LEE, J. BIOMOL. SCREEN., (1996), vol. 1, page 47
	- FOX ET AL., PROTEIN SCI, (1998), vol. 7, page 2249

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p